{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:15:51Z","timestamp":1787019351707,"version":"build-2736575974"},"reference-count":40,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Rh\u00f4ne Alpes Auvergne region","award":["IRICE RRA18 010792 01 \u2013 10365"],"award-info":[{"award-number":["IRICE RRA18 010792 01 \u2013 10365"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Med Oncol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Immune checkpoint inhibitors (ICIs) have shown efficacy in endometrial cancer (EC); however, their efficacy varies according to mismatch repair (MMR) status. Notably, even among patients with MMR-deficient (MMRd) or microsatellite instability-high (MSI-H) tumors, approximately one-third exhibit primary resistance to ICI monotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We aimed to characterize dissimilarities in the tumor immune microenvironment of ICI-treated MMRd\/MSI-H versus MMR-proficient (MMRp)\/microsatellite stable (MSS) EC, and to identify mechanisms of resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Adults with histologically confirmed advanced or recurrent EC treated with ICIs in 6 French comprehensive cancer centers were included. Patients without available archival formalin-fixed paraffin-embedded primary tumor samples were excluded. Clinical data were collected retrospectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients were classified as ICI-Responders or Non-Responders based on best objective response. A seven-color multi-immunofluorescence staining (CD20, CD4, CD8, FoxP3, CD68, CK, and DAPI) was performed on sections from archival formalin-fixed paraffin-embedded primary tumors. Cell densities and spatial proximity were analyzed using inForm software. T\/B lymphoid aggregates (LA) and tertiary lymphoid structures (TLS) were separately quantified. Microsatellite status, presence of LA\/TLS, and immune cell densities were correlated to response to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-one MMRd\/MSI-H and 12 MMRp\/MSS tumors were analyzed. We observed more MMRd\/MSI-H tumors with LA\/TLS compared to MMRp\/MSS cases: 81% versus 17%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2a7d\u20090.001. There were more CD8\n                      <jats:sup>+<\/jats:sup>\n                      T effector cells in the vicinity of B cells in MMRd\/MSI-H tumors compared to MMRp\/MSS tumors (1.26 (0\u20133.40) vs 0.49 (0\u20131.86),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017), suggesting cooperation between CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells and B cells in MMRd\/MSI-H tumors. No differences were shown in terms of the presence of LA\/TLS and the subsequent response to ICI in EC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.400). Using a multivariate logistic regression model, we found that a low density of CD68\n                      <jats:sup>+<\/jats:sup>\n                      tumor-associated macrophages (TAMs) in the stroma, was associated with response to ICI in EC (odds ratio\u2009=\u200911.67, 95% CI (1.69\u2013237.45),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033) and showed good accuracy in predicting response to ICI in the whole cohort (AUC\u2009=\u20090.75, 95% CI (0.59\u20130.91)).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We characterize the immune landscape in EC patients treated with ICIs. Distinct immune infiltrate patterns were observed in MMRd\/MSI-H and MMRp\/MSS tumors. A significant negative association between TAM density and ICI response was shown.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17588359251347364","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T12:17:46Z","timestamp":1754655466000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy"],"prefix":"10.1177","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-323X","authenticated-orcid":false,"given":"Olivia","family":"Le Saux","sequence":"first","affiliation":[{"name":"Cancer Research Center of Lyon, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, \u201cCancer Immune Surveillance and Therapeutic Targeting\u201d Team, 28 rue Laennec, Lyon 69008, France"},{"name":"National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Sabatier","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Paoli Calmettes, CRCM, Aix-Marseille University, Inserm, CNRS, Marseille, France"},{"name":"National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Treilleux","sequence":"additional","affiliation":[{"name":"Biopathology Department, Centre L\u00e9on B\u00e9rard, GINECO, Lyon, France"},{"name":"National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a-Isabelle","family":"Renaud","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Brachet","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France"},{"name":"National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5273-0561","authenticated-orcid":false,"given":"Jean-S\u00e9bastien","family":"Frenel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut de cancerologie de l\u2019ouest site Ren\u00e9 Gauducheau, Saint Herblain, France"},{"name":"National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Abdeddaim","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Centre de Lutte Contre le Cancer-Centre Oscar Lambret, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Berthet","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Lyon, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, \u201cCancer Immune Surveillance and Therapeutic Targeting\u201d Team, Lyon, France"},{"name":"Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barrin","sequence":"additional","affiliation":[{"name":"Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Colombe-Vermorel","sequence":"additional","affiliation":[{"name":"Biopathology Department, Centre L\u00e9on B\u00e9rard, GINECO, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Odeyer","sequence":"additional","affiliation":[{"name":"Biopathology Department, Centre L\u00e9on B\u00e9rard, GINECO, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Lain\u00e9","sequence":"additional","affiliation":[{"name":"EMS Team, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Caux","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Lyon, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, \u201cCancer Immune Surveillance and Therapeutic Targeting\u201d Team, Lyon, France"},{"name":"Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dubois","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Lyon, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, \u201cCancer Immune Surveillance and Therapeutic Targeting\u201d Team, Lyon, France"},{"name":"Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[{"name":"National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France"},{"name":"Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216334"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302312"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.034"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02132"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.04.007"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.02.006"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237041"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003777"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01874"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0424-2"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3241"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29040-x"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.08.028"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e318284e198"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31822c271f"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00324-8"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720948115"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0769-3"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101671"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000496"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002230"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.101915"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000482"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2655"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00830"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03023"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3723"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.084"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3836"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.02.002"},{"issue":"3","key":"e_1_3_4_38_2","first-page":"285","article-title":"Tingible body macrophages in regulation of germinal center reactions","volume":"6","author":"Smith JP","year":"1998","unstructured":"Smith JP, Burton GF, Tew JG, et al. Tingible body macrophages in regulation of germinal center reactions. Dev Immunol 1998; 6(3\u20134): 285\u2013294.","journal-title":"Dev Immunol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1724763"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00620-6"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.6858"}],"container-title":["Therapeutic Advances in Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17588359251347364","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17588359251347364","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17588359251347364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:32:39Z","timestamp":1777588359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17588359251347364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"alternative-id":["10.1177\/17588359251347364"],"URL":"https:\/\/doi.org\/10.1177\/17588359251347364","relation":{},"ISSN":["1758-8359","1758-8359"],"issn-type":[{"value":"1758-8359","type":"print"},{"value":"1758-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"article-number":"17588359251347364"}}